BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17582610)

  • 1. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
    Dua P; Ingle A; Gude RP
    Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2012 Dec; 66(8):617-26. PubMed ID: 23089470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells.
    Dua P; Gude RP
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):195-202. PubMed ID: 16331498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components.
    Ratheesh A; Ingle A; Gude RP
    Cancer Biol Ther; 2007 Nov; 6(11):1743-52. PubMed ID: 17986856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity.
    Karasawa K; Sugiura N; Hori Y; Suzuki S; Onaya J; Sakurai K; Kimata K
    Clin Exp Metastasis; 1997 Mar; 15(2):83-93. PubMed ID: 9062384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.
    Jain M; Ratheesh A; Gude RP
    Chemotherapy; 2010; 56(1):82-8. PubMed ID: 20299795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
    Kang IC; Kim DS; Jang Y; Chung KH
    Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic efficacy of niosomal pentoxifylline and its combination with activated macrophages in murine B16F10 melanoma model.
    Gaikwad SY; Jagtap AG; Ingle AD; Ra SG; Gude RP
    Cancer Biother Radiopharm; 2000 Dec; 15(6):605-15. PubMed ID: 11190492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice.
    Sant VP; Nagarsenker MS; Rao SG; Gude RP
    Cancer Biother Radiopharm; 2003 Oct; 18(5):811-7. PubMed ID: 14629829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of antimetastatic activity of pentoxifylline in B16F10 and B16F1 melanoma cells through inhibition of glutathione content.
    Shukla V; Gude RP
    Cancer Biother Radiopharm; 2003 Aug; 18(4):559-64. PubMed ID: 14503950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation.
    Dua P; Gude RP
    Eur J Cancer; 2008 Jul; 44(11):1587-95. PubMed ID: 18495474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
    Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
    Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
    Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lung and liver tumor colonies in mice pretreated with suramin.
    Sola F; Farao M; Marsiglio A; Mariani M; Grandi M
    Invasion Metastasis; 1993; 13(3):163-8. PubMed ID: 8112976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.
    Goel PN; Gude RP
    Mol Cell Biochem; 2011 Dec; 358(1-2):141-51. PubMed ID: 21725843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent.
    Gude RP; Ingle AD; Rao SG
    Cancer Lett; 1996 Sep; 106(2):171-6. PubMed ID: 8844969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
    Siveen KS; Kuttan G
    Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
    Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
    Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells.
    Goel PN; Gude RP
    Biomed Pharmacother; 2014 Mar; 68(2):191-200. PubMed ID: 24373697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline.
    Gude RP; Binda MM; Presas HL; Klein-Szanto AJ; Bonfil RD
    J Biomed Sci; 1999; 6(2):133-41. PubMed ID: 10087444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.